Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.79 - $2.85 $29,893 - $47,595
16,700 Added 14.21%
134,184 $305,000
Q3 2022

Aug 11, 2023

BUY
$1.87 - $3.0 $74,239 - $119,100
39,700 Added 51.04%
117,484 $234,000
Q3 2022

Nov 03, 2022

BUY
$1.87 - $3.0 $74,239 - $119,100
39,700 Added 51.04%
117,484 $236,000
Q1 2022

Aug 11, 2023

SELL
$2.8 - $6.21 $111,160 - $246,537
-39,700 Reduced 33.79%
77,784 $288,000
Q1 2022

May 20, 2022

BUY
$2.8 - $6.21 $217,795 - $483,038
77,784 New
77,784 $278,000

Others Institutions Holding LIAN

About LianBio


  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $31.4M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.